Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health Data Movers Inc (HDM) Ranks No. 475 on the 2020 Inc. 500


News Image

HDM has continued to build on their early reputation as the “must call” firm for the toughest healthcare IT projects

Inc. magazine revealed on August 12, 2020, that Health Data Movers Inc. (HDM) is No. 475 on its annual Inc. 500 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

Founded in 2012, with an initial focus on transplant, data conversion, and Epic consulting services, HDM’s offerings have grown to include interface development, in-house full-stack development, project management, and EHR consulting services across all major vendors. Still actively managed by founding partners Brian Battistone, Greg Georgatos, and Tyler Smith, the firm has continued to build on their early reputation as the “must call” firm for the toughest healthcare IT projects.

“We are thrilled to be part of the esteemed Inc. 500 list!” said Smith. “This honor underscores the importance of our incredible HDM team. Fueled by a desire to improve healthcare with better data and better tools, HDM’s exceptional employees deserve credit for propelling us to #475. Greg, Brian and I could not be prouder or happier to work with such an amazing group.”

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

The annual Inc. 5000 event honoring the companies on the list will be held virtually from October 23 to 27, 2020. As always, speakers will include some of the greatest innovators and business leaders of our generation.

About Health Data Movers (HDM)

Health Data Movers’ mission is to improve the lives of patients and providers by unleashing the potential of healthcare data and technology. HDM executes data conversions, EHR implementations, and development projects with the nation’s top healthcare provider organizations, medical device firms, and digital health enterprises.

The company works with organizations that put their patients first and strive for the seamless and safe transfer of medical information.

Follow HDM on LinkedIn and Twitter for more exciting updates.

Inc. 5000 Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.

Share article on social media or email:



Simplify Compliance Launches Inspired T-Shirt Charity to Support Those Adversely Impacted by the COVID-19 Pandemic


This campaign enables our customers to take an active role in helping their communities and spreading the message that, regardless of what the future holds, we will persevere.

Simplify Compliance is excited to announce the launch of a new campaign that will donate all proceeds from the sale of inspirational T-shirts to three worthy charities.

The “Knowledge Over the Unknown” T-shirt campaign, a nod to the company’s belief that knowledge is the primary ingredient to business success, will raise funds for the New York-Presbyterian’s Healthcare Workers Fund, FeedingAmerica, and GoFundMe’s Small Business Relief Fund. In Simplify Compliance’s online apparel store, individuals can choose from over five unique designs and select which charity they want to support with their purchase at checkout.

“As a business, we’ve been looking for innovative ways to support our frontline heroes, essential workers, and families across the country during this time. While we’re not an apparel company, this campaign enables our customers to take an active role in helping their communities and spreading the message that, regardless of what the future holds, we will persevere,” says Kim St. Lawrence, Vice President of Marketing at Simplify Compliance.

The “Knowledge Over the Unknown” custom apparel store can be accessed at https://interactive.blr.com/charity-tees.

The company is supporting its community and customers in a business capacity, as well, by offering complimentary access to acute respiratory illness response and stress management training, sending masks to community members, and discounting essential education for healthcare workers.

“As a knowledge provider, it’s our responsibility to double down, get creative, and implement new training courses, resources, and solutions to help support businesses during this turbulent time,” says Dan Oswald, CEO of Simplify Compliance.

The company has curated additional knowledge resources, such as news articles, white papers, free informational webinars, and more, in a universal hub for all pandemic response-related solutions, including:

Sister brand Bluepoint Leadership Development is also offering complimentary virtual facilitator-led workshops on topics like leading remote teams, building resilience, managing change, communicating effectively in times of crisis, and more. View upcoming virtual workshops by visiting https://interactive.blr.com/bluepoint-virtual-solutions.

About Simplify Compliance

For over 40 years, Simplify Compliance has provided the nation’s top businesses with the latest knowledge and regulatory information to make decisive, positive, and productive decisions in a continuously evolving business environment. Serving a range of industries, including health care, human capital management, and telecommunications, Simplify Compliance provides timesaving products and solutions that help businesses monitor compliance, implement best practices, and optimize financial performance to achieve their goals. Simplify Compliance proudly operates BLR®, HCPro, DecisionHealth, HealthLeaders, CCMI, and sister brand Bluepoint Leadership Development. For more information, visit http://www.simplifycompliance.com.

Share article on social media or email:

A New Healing Blu Light Shines in Warrenton, Virginia


“A New Pathway of Healing on the East Coast.”

There’s a cool, blu wind blowing through the Shenandoah Mountains and into Warrenton this August with the arrival of a new Blu Room offering UVB narrowband light and sound therapy. Sarah Shores along with Mark Kerski have now opened Warrenton Wellness providing Blu Room services to the East Coast for the first time! Warrenton Wellness is located at 83 West Lee Highway in Warrenton, VA. To schedule an appointment, please call (540) 216-2524 or visit http://www.warrentonwellness.com.

Clients enjoy the Blu Room for stress reduction, wellness, relaxation, and promotion of healing. Around the world, the Blu Room is enjoyed by working professionals, young people, athletes, retirees, active duty military and many others.

Sarah Shores is excited to bring new wellness technology to Warrenton. “We are thrilled to open our doors to bring about a whole new pathway of healing, contributing to the existing spectrum of alternative care and providing complimentary health and wellness support when combined with traditional medicine. We welcome you to come and have a Blu Room experience!”

The Blu Room is a patented technology that shields users from the outside world and wraps users in an atmosphere of soft blue and ultraviolet light so the mind is free to relax. The Blu Room helps anyone who wants to step out of the daily routine including children, adults and the elderly. The sessions consist of 20 minutes of deep relaxation inside a futuristic octagon bathed in blue and UVB light. Users report a wide range of benefits such as deepened focus, a faster healing process, greater self-awareness, pain relief, alleviating stress and anxiety, as well as overall improved health.

The Blu Room is a tool that provides many benefits, including:

  • Increased Vitamin D
  • Relief from pain, stress & anxiety
  • Deep Relaxation
  • Accelerated healing
  • Increased creativity
  • Moving into the higher frequencies of gratitude and unconditional love

To date, over 200,000 Blu Room sessions have been provided in the USA and 11 other countries. There are 36 operational Blu Room locations with 11 additional locations under construction. Countries with Blu Room services include Argentina, Austria, Canada, Colombia, Germany, Italy, Japan, Mexico, Romania, Switzerland, Taiwan, and USA. Five locations are for private use or employee-only programs and the remaining locations are open to the public in either clinical or spa/wellness settings.

About the Blu Room

The Blu Room is a patented technology that creates an atmosphere to insulate users from the outside world. It provides the user with a mind/body/spirit consciousness-lifting environment that can augment one’s state of personal wellbeing and creative focus. Users have reported a wide range of benefits including deep relaxation, relief from mental stress and anxiety, relief from physical pain, faster healing processes, increased creativity, greater self-awareness. For more information, please visit: http://www.bluroom.com.

Share article on social media or email:

W.S Darley & Co. Partners With Homethrive to Offer Family Elder Care Benefit to Employees


News Image

Today, W.S. Darley & Co. announced they are partnering with Homethrive, a family elder care coordinator, to offer their employees a fully-covered family caregiver service as part of the company’s broader benefits package. Homethrive will be offered to all employees starting immediately. Through Homethrive, company employees will have access to Care Guides assigned to each family who provides coaching and concierge services for aging loved ones living at home, reducing employee caregiving effort and stress. Offering a family caregiving benefit is part of W.S Darley & Co’s larger commitment to empower and recognize their employees by providing them resources to achieve their full career potential. W.S Darley & Co. is a family-owned business that strives to create a culture and environment where employees are treated as if they were family.

Family care obligations affect most adults throughout their careers. According to AARP*, at least 42 percent of adults provide caregiving support to at least one parent. 60 percent of these caregivers reported that their caregiving responsibilities have affected their work. The impact of caregiving responsibilities has the potential to cause employees to suffer personal health issues, not fully achieve their potential in the workplace, lose productivity, or possibly end a successful career early.

“At W.S. Darley & Co. we pride ourselves in our benefits package offered to our employees. When Homethrive presented a caregiving benefit that would help employees and their families this decision was a no brainer. Our partnership with Homethrive has been amazing. The Homethrive team is passionate, knowledgeable, and professional. We are happy to offer this unique benefit to our employees and to partner with the team at Homethrive,” says Kara Paleothodoros, HR Manager, W.S. Darley & Co.

“We are thrilled to be partnering with W.S. Darley & Co. to offer a caregiving benefit to help support their employees who are family caregivers,” says David Greenberg Co-founder & Co-CEO at Homethrive. “The W.S. Darley & Co. team does an amazing job supporting first responders and emergency management professionals with the equipment they need to take care of others in distress. It’s our honor to offer a service to help take care of them by easing the stress of caregiving.”

Homethrive works by matching each employee with a Care Guide that serves as a family coach. Care Guides work with employees to learn about their loved one, identify home safety opportunities, achieve goals, as well as recommend and arrange services to help the employee shoulder the burden of caregiving.

*https://www.aarp.org/content/dam/aarp/ppi/2015/caregiving-in-the-united-states-2015-report-revised.pdf

About Darley:

Founded in 1908, W. S. Darley & Co. is a family owned and operated business which manufactures and distributes firefighting and defense equipment. Our mission is to passionately serve the world’s first responder and tactical communities by providing high quality, safe and innovative products with unmatched commitment and service. Darley is headquartered in Itasca, IL and has manufacturing, engineering and operations in Chippewa Falls, WI, Janesville, IA and Grand Rapids, MI.

For more information please call or visit us at:

Toll Free: 800.323.0244

International: 630.735.3500

http://www.darley.com

http://www.edarley.com

About Homethrive:

Homethrive is a family elder care coordinator that reduces the work, worry, and stress on a family caregiver. The company takes the uncertainty and stress out of caring for an aging loved one by offering expert coaching and concierge services by assigning an experienced Care Guide to each family. The company’s Care Guides also recommend and arrange any necessary third-party supportive services to provide meals, transportation, home care, medication delivery, or other services. To learn more, visit http://www.homethrive.com.

Share article on social media or email:

Inc. Magazine Unveils Its Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000


Inc. magazine revealed that Network Partners is No. 728 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

“The Network Partners team is honored to be recognized by the Inc. 5000 as one of the fastest growing, privately held companies in the nation,” said Tim Early, CEO of Network Partners. “Our growth in the professional services sector supporting the life sciences industries is a testament to answering the challenge of providing top talent that delivers results. We are very excited about the future, as the current global pandemic has accelerated our model of providing key experienced resources whose work product is effective and efficient when completed remotely and being available on-site when required by our clients.”

Not only have the companies on the 2020 Inc. 5000 been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists as well. The 2020 Inc. 5000 achieved an incredible three-year average growth of over 500 percent, and a median rate of 165 percent. The Inc. 5000’s aggregate revenue was $209 billion in 2019, accounting for over 1 million jobs over the past three years.

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000. The top 500 companies are also being featured in the September issue of Inc., available on newsstands August 12.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

The annual Inc. 5000 event honoring the companies on the list will be held virtually from October 23 to 27, 2020. As always, speakers will include some of the greatest innovators and business leaders of our generation.

Network Partners is a professional services firm providing the highest quality of Subject Matter Experts to the medical device, pharmaceutical and biopharmaceutical industries. We set the standard with our excellence in Packaging Engineering, Labeling and Regulatory Affairs by ensuring total compliance when bringing our client’s life-saving products to market.

CONTACT:     

Karen Polkinghorne

574-377-7151

karen.polkinghorne@networkpartners.com

More about Inc. and the Inc. 5000

Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

For more information on the Inc. 5000 Conference, visit http://conference.inc.com/.

Share article on social media or email:

Scientist.com Named One of America’s Fastest-Growing Privately-Owned Companies for Fourth Consecutive Year


News Image

“Revenue growth means little if we’re not making people’s lives better, which is why we’re doing everything in our power to help scientists in the biopharma industry continue their search for new cures and vaccines for COVID-19 and other diseases.”—Kevin Lustig, PhD, Scientist.com’s CEO and Founder.

Inc. magazine today announced that Scientist.com, the healthcare industry’s leading marketplace for life science research, ranked no. 909 on its Inc. 5000 list, a ranking of the nation’s fastest-growing private companies. This is the fourth year in a row that Scientist.com has made the list, which is a snapshot of the most successful independent small businesses in the US.

“Revenue growth means little if we’re not making people’s lives better,” stated Kevin Lustig, PhD, Scientist.com’s CEO and Founder. “We are doing everything in our power to help scientists in the biopharma industry continue their research virtually as they search for new cures and vaccines for COVID-19 and other diseases. Working together without regard to race, gender or political affiliation, we can eliminate COVID-19 and every human disease.”

Scientist.com has spent the last thirteen years building an award-winning marketplace that helps scientists focus more on science and less on paperwork. Its Biotech as a Service(TM) platform helps researchers test more ideas in less time and at lower cost. It digitizes a company’s entire research operations, automatically tracking purchases, managing contracts, handling payments and generating business intelligence reports. Scientist.com helps biotech companies do groundbreaking R&D faster than ever before.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

Complete results of the Inc. 5000, including company profiles and industry rankings, can be found at https://www.inc.com/inc5000/list/2019.

About Scientist.com

Scientist.com is the pharmaceutical industry’s leading AI-powered marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saving time and money, reducing risk and providing access to the latest innovative tools and technologies. Scientist.com operates enterprise R&D marketplaces for 24 of the world’s top 30 pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised $39 million from 5AM Ventures, Transformation Capital and Bootstrap Ventures among others.

Visit scientist.com to learn more.

Join Scientist.com on social media: LinkedIn, Twitter, YouTube, Facebook and Instagram

Media Contact:

Sean Preci

Director of Communications

+1 858 455-1300 ext. 401

Share article on social media or email:



Augusta-Richmond, Georgia, Ranks #1 in the Companion Animal Parasite Council’s Top 10 Cities HOOKWORM Report for July


The Companion Animal Parasite Council (CAPC) — the nation’s leading source on parasitic diseases that threaten the health of pets and people — issued the CAPC Top 10 Cities Monthly HOOKWORM Report.

An increase in hookworm prevalence not only alerts communities to a heightened threat to the health of dogs and cats, but it also warns of an increased threat to the health of children and families who can potentially contract hookworm infection.

The Companion Animal Parasite Council (CAPC) — the nation’s leading source on parasitic diseases that threaten the health of pets and people — today issued the CAPC Top 10 Cities Monthly HOOKWORM Report for July — with Augusta-Richmond, Georgia topping the list as #1 across the country.

The new monthly report alerts pet parents, veterinarians and pet-related services about the emerging threat of hookworm — a zoonotic, parasitic disease threatening the health of both pets and people. The report identifies U.S. metro areas experiencing the highest percentage increase in positive hookworm tests in the last 30 days.

“The recent outbreak of COVID-19, with its animal origin, has made people acutely aware of the close relationship between animal and human health — and the need to regularly monitor disease at the local level,” said Dr. Chris Carpenter, DVM and CAPC’s Chief Executive Officer. “With the growing threat of hookworm, CAPC expands its decade-long mission to regularly monitor parasitic diseases in communities across the U.S. with its new CAPC Top 10 Cities Monthly HOOKWORM Report.”

Canine and feline hookworm can be lethal, particularly for puppies and kittens. In national data collected July 1 – 31, 2020, these 10 U.S. cities had the highest percentage increase in positive hookworm tests:

1) Augusta-Richmond, GA

2) Sioux Falls, SD

3) San Francisco, CA

4) Dover, DE

5) Waco, TX

6) Newport News, VA

7) Cedar Rapids, IA

8) Manchester, NH

9) Paterson, NJ

10) Fort Collins, CO

“An increase in hookworm prevalence not only alerts communities to a heightened threat to the health of dogs and cats, but it also warns of an increased threat to the health of children and families who can potentially contract hookworm infection,” said Dr. Craig Prior, BVSC, CVJ, CAPC board member.

A recent study shows a 47% increase in the number of canine hookworm cases in the U.S. from 2012-2018 (Parasites & Vectors, 2019) — with CAPC maps reporting 212,863 positive cases of canine hookworm infections nationwide in 2018.

“This demonstrates how vital it is for dogs and cats to be protected against hookworm parasites with broad-spectrum, year-round preventatives and at a minimum bi-annual testing,” Prior added. “By protecting your pet, you are protecting other pets, your family, other families — and your entire community.”

What are hookworms?

Hookworms are parasites that live in contaminated soil and infect dogs and cats in all 50 states. Hookworm disease can cause debilitation or death, especially in puppies and kittens. Pets can become infected by hookworm larvae penetrating the skin, licking paws, chewing contaminated toys, or ingesting infected prey such as mice. Larvae migrate until they become adults in the intestines. Hookworm can also be transmitted from nursing mothers to puppies and kittens.


  • In dogs, signs of hookworm infection may include dark, tarry diarrhea, anemia, loss of appetite, weight loss and skin lesions. Puppies infected with hookworms are at greater risk due to blood loss.
  • In cats, signs of hookworm infection may include diarrhea or anemia. Respiratory disease and pneumonia may occur as larvae migrate through the lungs. In kittens, hookworms can be fatal due to blood loss.
  • In people, hookworm infection is generally displayed on the skin with itching at the infection site and appears as cutaneous larval migrans — a winding, threadlike, raised rash. People should avoid walking barefoot in areas of potential contamination and wear gloves and shoes when gardening.


Contributing factors to increase in hookworm infection

Pets living in cities on this month’s CAPC Top 10 Cities HOOKWORM Report may have been exposed due to several risk factors, including environmental contamination from pet owners who don’t pick up dog stools, the growing popularity of dog parks, and pet owners’ noncompliance in administering year-round, broad-spectrum parasite control preventatives.

Environmental contamination in neighborhoods — and your own backyard

Hookworms produce a massive number of eggs on a daily basis, heightening the risk of environmental contamination. Any outdoor area where dogs and cats have access can become reservoirs of hookworm larvae. Typical areas of contamination include neighborhood streets, common areas, backyards, gardens, sandboxes, beaches and rest areas. Regularly removing feces is critical to preventing the spread of hookworms.

In communities across the country, dog owners not picking up their dog’s stool is a contentious issue — and for good reason. “Dog owners need to always pick up fecal waste in public areas — and at least once a week in their own backyards. If not, they are allowing hookworm larvae to live in the environment, and hookworm eggs are hearty with the ability to live for months.”

According to the U.S. Environmental Protection Agency, 40% of dog owners don’t pick up dog stool. “It’s more than a cosmetic issue,” Prior added. “Pet owners who are irresponsible in picking up after their dogs are putting the health of their own dog, other dogs — and the health of everyone in their community at risk.”

Growth of dog parks

Dog parks are quickly becoming a standard feature in many communities. A recent study by The Trust for Public Land reported 744 off-leash dog parks in the top 100 cities in the U.S. in 2018 — a 40% increase since 2009. “The popularity of dog parks is probably a major factor in the increased number of hookworm cases. Unlike boarding or day care facilities, dog parks don’t require proof of immunization and parasite protection,” Prior said. “And while dog parks provide a unique opportunity for dogs to exercise, it’s not uncommon for dog owners to socialize, and while not paying close attention — even for a few minutes — their dog defecates, leaving stool behind as a potential source of infection.”

All pets protected and tested

CAPC recommends that all dogs and cats be protected with monthly broad-spectrum parasite control with efficacy against hookworms year-round. CAPC also recommends puppies and kittens be tested at least four times in the first year of life for hookworms and other intestinal parasites; and at least two times per year in adults — even if they are on year-round preventives. To more closely pinpoint risk areas for hookworm, CAPC Parasite Prevalence Maps (http://www.capcvet.org) provide hookworm parasite prevalence in every county across the U.S.

“For nearly a decade, CAPC has been a national leader in monitoring parasitic diseases that threaten pets and people with timely, local disease prevalence maps,” Carpenter said. “It’s our hope that the new CAPC Top 10 Cities HOOKWORM Report will prompt important conversations between pet owners and their veterinarians about hookworm protection.”

ABOUT CAPC

The Companion Animal Parasite Council (http://www.capcvet.org) is an independent not-for-profit foundation comprised of parasitologists, veterinarians, medical, public health and other professionals that provides information for the optimal control of internal and external parasites that threaten the health of pets and people. Formed in 2002, CAPC works to help veterinary professionals and pet owners develop the best practices in parasite management that protect pets from parasitic infections and reduce the risk of zoonotic parasite transmission.

Johnstech International Steps Up Covid-19 Precautions with State-of-the-Art Air Cleaning System for Minneapolis Manufacturing Facility


Leading semiconductor test manufacturer Johnstech International added a state-of-the-art air cleaning system to their already robust rooftop HVAC units at their Minneapolis headquarters in an increased effort to protect its international supply chain. This change comes after weeks of expanding production capacity in response to an increase in demand from customers who provide semiconductor chips used in critical medical devices and communications infrastructure.

The cleaning systems are manufactured by Global Plasma Solutions and utilize bi-polar ionization to reduce airborne pathogens including coronavirus, norovirus, and MRSA. Director of Operations John G. Roy explains that since the beginning of the COVID-19 pandemic, Johnstech has taken an assertive approach to support the business. “We’re proud to be a Minnesota manufacturer making a global impact on technology,” says Roy. “Adding this air cleaning system to each of the 22 units is just one more layer to protect our employees and our customers who depend on our business.”

Johnstech International is a key supplier to semiconductor companies across many essential industries including medical devices, communications, and critical infrastructure has been committed to protecting its operations and employees during this pandemic. Prior to adding the new air cleaning system, Johnstech had already expanded their safety stands to include frequent facility cleaning, adding an on-site nurse for temperature checks, remote working, and instituting strict social distancing, and mandating mask-wearing.

JOHNSTECH INTERNATIONAL is a global R&D leader in the field of testing, providing reliable, cost-effective testing solutions for automotive, commercial, and industrial applications. Founded in 1991 by David Johnson, Johnstech works hand-in-hand with the world’s most respected OSATs, foundries, and EDA companies to develop the most precise and dependable test contactors on the marketplace today. For more info, visit http://www.johnstech.com.

Share article on social media or email:

Health Testing Centers Research for Assessing COVID-19 Risk Factors


Health Testing Centers releases COVID-19 research guide.

“These easily accessible lab tests should be considered as part of an individualized strategy to manage your coronavirus health concerns”

Health Testing Centers has published a COVID-19 research guide compiling the latest findings and evidence on useful clinical markers for COVID-19 preparedness to assess your health risks. These easily accessible lab tests should be considered as part of an individualized strategy to manage your coronavirus health concerns:

1) Vitamin D, 25 Hydroxy

Vitamin D deficiency affects 35% of adults and 61% of the elderly population in the United States. Clinical evidence indicates that Vitamin D levels are deeply correlated to patient outcome following a COVID-19 infection. One recent study showed patients with severe Vitamin D deficiencies are twice as likely to develop life-threatening complications after exposure to the virus.

2) Hemoglobin A1C (Blood Sugar)

The correlation between blood sugar and COVID-19 outcomes is emerging. Sugar impairs immune function, seriously affecting and potentially crippling the immune system’s ability to subdue COVID-19 when it enters the body. Half of COVID-19 patients that require hospitalization have dangerously elevated blood sugar levels (hyperglycemic). Taking steps to understand your blood-sugar measurements and reduce blood-sugar concentrations is an easy step in COVID preparedness.

3) C-Reactive Protein, CRP (Inflammation)

Inflammation drives much chronic disease with links to diabetes, cancer, autoimmune disorders, heart disease, and other major chronic illnesses. Inflammation hinders the immune system’s ability to effectively neutralize an invading pathogen. When uncontrolled inflammation can lead to serious and often-fatal complications. In COVID-19 cases, unchecked inflammation can lead to a deadly cytokine storm. Understanding your current inflammation levels should be a part of assessing your overall risk of complications from COVID-19.

4) Zinc

Zinc is believed to support the immune response by halting viral replication, cutting off a viral infection’s spread. Growing research shows zinc levels to be a possible predictor of COVID-19 mortality among infected patients. With as much as 25% of the population suffering from zinc deficiency intervention in high risk groups such as the elderly through immune-boosting zinc supplementation is highly recommended.

5) Iron and Ferritin                                                                                                                                                

Iron plays an important role in generating new red blood cells and hemoglobin that helps carry oxygen throughout your body. Ferritin is a protein that stockpiles iron, making it an accurate gauge of how much iron is in your body.

New research indicates that elevated ferritin levels represent a substantial risk factor for hospitalized COVID-19 patients. Patients abnormally high ferritin levels suffer serious complications associated with COVID-19 infections, including cytokine storm response, at substantially greater rates than patients with normal iron levels.

Another study, found a negative correlation between COVID-19 severity and iron levels in the blood. As iron levels dropped in patients, the likelihood of experiencing life-threatening inflammation increased, particularly in the lungs.

6) Interleukin-6 protein (IL-6) Levels and Genetic Markers    

There is evidence that patients with a genetic predisposition for abnormally upregulated interleukin-6 (IL-6) cell activity, suffering from a viral infection may experience an increase in levels of IL-6. These higher levels of IL-6 have been linked to the deadly cytokine storm response to COVID-19. Specifically, elevated levels of IL- 6 and ferritin have been noted.

IL-6 cells are pro-inflammatory components of the immune system. Elevated levels or over production of IL-6 in the body have been linked to the systemic inflammatory process. In the case of a patient with such a genetic predisposition and elevated IL-6 levels, IL-6 inhibitors may be useful to slow the inflammatory cells’ activity.        

Clinically Assessing COVID-19 Risk                                                                                    

Health Testing Centers is committed to equipping patients with lab tests, home test kits, and online resources to develop an individualized strategy to manage your health. If you are concerned about COVID-19 susceptibility the findings discussed above and lab tests to quantify these factors could provide a helpful analysis of your individual risk as it pertains to the coronavirus.

About Health Testing Centers

Since 1980, Health Testing Centers has enabled consumer access to laboratory testing, including Doctor’s oversight, and providing helpful resources for individuals to understand their health. Health Testing Centers works nationwide with major laboratories, as well as the premier specialized laboratories to provide an online menu of best-in-class testing, delivered with a 100% satisfaction guarantee and the highest level of service.

For more information, please visit our website at http://www.HealthTestingCenters.com.

Share article on social media or email:

NuView NV-VPAC1 Uniquely Positioned to Find the Overexpression of Specific Receptors Appearing only on the Surface of Malignant Cells for Early Cancer Diagnosis, Therapy


By creating a precision cancer theranostic, a new field of medicine is emerging.

The NV-VPAC1 is a unique molecular tool ,with the ability to diagnose cancer in vitro, to localize it in vivo, to treat the primary and metastatic lesions and to allow one to determine the efficacy of therapeutic interventions

To meet the demand for more effective, modern choices to confirm and treat cancer, the clinical stage oncology company NuView Life Sciences has introduced a proprietary NV-VPAC1 peptide platform invented by Dr. Mathew Thakur and colleagues at Thomas Jefferson University in Philadelphia, PA.

A proprietary peptide construct targets the Vasoactive Intestinal Peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP) receptors known as VPAC1, VPAC2, and PACAP overexpressed on the surface of cancer cells. Combined with medical imaging methods, NuView’s test provides physicians a more precise diagnosis and allows for targeted therapy delivery. The Cancer Consortium recently called NuView’s precision medicine technology a “breakthrough…uniquely positioned to confirm cancer” on the cell surface with greater than 95% sensitivity. (1)

NuView Seeks to Help Patients Avoid Surgical Biopsy

For patients, theranostics diagnostics avoids painful surgical biopsy and one-size-fits-all cancer treatment. The Society of Nuclear Medicine, which advances the science of molecular imaging, called theranostics “paintball targeting” cancer cells with precision therapy. (2)

To make this technology available as quickly as possible, NuView is collaborating with SpectronRx—a company that provides therapeutic and diagnostic isotopes for clinical and research use. The two are working together to produce the NV-VPAC1 in adherence to the quality standards of the Good Manufacturing Practice (GMP) system.

“SpectronRx has the staff, facilities and expertise to scale up and manufacture both the diagnostic and therapeutic,” stated John Zehner, the CEO of SpectronRx. “We have tremendous experience with the labeling and distribution of copper isotopes labeled to various molecular entities. Our facility was approved for three Positron Emission Tomography diagnostic drugs in 2012, we anticipate an additional FDA approval for a therapeutic in the next few months. We look forward to assisting with NuView’s approval in the very near future.”

Clinical Testing Yields 97% Accuracy

Diagnostic imaging studies performed at Thomas Jefferson University (TJU) using the NV-VPAC1 peptide positively confirmed or ruled out the presence of cancer cells for breast, prostate and other cancers when combined with Positron Emission Tomography (PET) (3). Dr. Thakur and a member of NuView’s Clinical Collaborators panel, and his team at TJU noninvasively collect cells from bodily fluid (urine for prostate, nipple discharge for breast or lung lavage (rinse) for lung cancer imaging). The cells in these fluids are then exposed to NV-VPAC1 that binds with protein receptors on the surface of cancer cells allowing to detect cancer non-invasively under a microscope. As the cells are collected and tested separately, the patient is not exposed to any radiation. In clinical trials, TJU reports 97% accuracy in diagnosing prostate cancer, with similar success rates in an as-yet limited samples with lung and breast cancer.

The result is radioactive illumination under PET imaging which highlights occult malignant lesions efficiently. The results from the in vivo and in vitro studies can benefit everyone—improved diagnostic and therapeutic information for physicians along with increased relief and affordability for patients.

Precision Cancer Diagnostics and Therapeutics Theranostics

With over 100 types of cancers on record, each type of cancer is prone to diagnostic errors, costly screenings, and ineffective therapy. For example, approximately 50% of women experience false-positive mammography results, which leads many patients to be less likely to get future cancer screenings. (4) Such instances contribute to the estimated $200 billion in annual expenses due to unnecessary medical testing. (5)

However, by creating a precision cancer theranostic, a new field of medicine is emerging that combines a paired diagnostic with treatment modalities to provide a more personalized and precise approach. (6)

“The NV-VPAC1 is a unique molecular tool, with the ability to diagnose cancer in vitro, to localize it in vivo, to treat the primary and metastatic lesions and to allow one to determine the efficacy of therapeutic interventions,” says Dr. Thakur.

Future Implications

Using the NV-VPAC1 peptide construct enables a more complete approach to disease management, combining both a binary diagnostic with a cell-specific therapy delivery mechanism.

“It is important to recognize that a fundamental shift is underway within our industry and the technologies that we believe in will drive our greatest opportunities,” says Paul Crowe, the CEO of NuView Life Sciences.

Crowe predicts that with better diagnostic capabilities and targeted treatments appropriate to individual patients, it will reduce costs to both patients and third-party insurance payers in the coming years. He believes NuView’s products are a solution to the demands for improved cancer diagnostic imaging and therapy worldwide.

About NuView Life Sciences

Founded in 2005, NuView Life Sciences is a clinical-stage oncology company located in Park City, Utah, advancing the way cancer is diagnosed and treated in our modern healthcare system. NuView is focused on creating precision binary cancer diagnostics and theranostics, providing clinicians more choices to improve patient outcomes while reducing healthcare costs through the development and clinical application of its exclusive peptide analog technology, NV-VPAC1(TM). Led by a team of industry experts with decades of combined experience in healthcare and medical imaging technologies, NuView is poised to introduce a new cancer diagnostic technology and subsequently deliver a theranostic approach for effectively treating cancer. To learn more, visit http://www.nuviewlifesciences.com.

1. Staff Writer, “Breakthrough Precision Medicine Technology for Non-Invasive Approach to Detecting Cancer”, The Cancer Consortium, 25 July 2019. thecancerconsortium.org/2019/07/breakthrough-precision-medicine-technology-for-non-invasive-approach-to-detecting-cancer/

2. Staff Writer, “Theranostics: Paintball Targeting of Cancer Cells Combined with Precision Therapy”, Medical Xpress, 13 September 2017. medicalxpress.com/news/2017-09-theranostics-paintball-cancer-cells-combined.html

3. Staff, “Laboratories of Radiopharmaceutical Research”, Laboratories of Radiopharmaceutical Research – Thomas Jefferson University – Thomas Jefferson University. jefferson.edu/university/jmc/departments/radiology/research/laboratories-of-radiopharmaceutical-research.html

4. Nam, James, “False-Positive Cancer Screening Results May Increase Likelihood of Future Screenings,” Oncology Nurse Advisor; 24 April 2018. oncologynurseadvisor.com/home/cancer-types/general-oncology/false-positive-cancer-screening-results-may-increase-likelihood-of-future-screenings/

5. Terhune, Chad, “Americans waste $200 billion every year on medical tests they don’t need, experts say”, Los Angeles Times, 25 May 2017. latimes.com/business/la-fi-medical-tests-20170526-story.html

6. Staff, “Peptide Therapeutics Market”, Transparency Market Research, 2019. transparencymarketresearch.com/peptide-therapeutics-market.html